UK markets closed
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • FTSE 250

    22,324.19
    -210.95 (-0.94%)
     
  • AIM

    1,229.80
    -11.57 (-0.93%)
     
  • GBP/EUR

    1.1636
    -0.0053 (-0.46%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • BTC-GBP

    24,979.83
    -1,143.45 (-4.38%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • DOW

    33,290.08
    -533.37 (-1.58%)
     
  • CRUDE OIL

    71.50
    +0.46 (+0.65%)
     
  • GOLD FUTURES

    1,763.90
    -10.90 (-0.61%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.68 (+0.85%)
     
  • DAX

    15,448.04
    -279.63 (-1.78%)
     
  • CAC 40

    6,569.16
    -97.10 (-1.46%)
     

The global molecular biology enzymes and kits & reagents market is projected to USD 29.7 billion by 2026 from USD 15.3 billion in 2021, at a CAGR of 14.2%

·4-min read

during the forecast period. The rising number of genome projects coupled with reducing genetic analysis costs helps advance research in various domains, such as disease treatment, personalized medicine, and microbial genetics.

New York, June 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Molecular Biology Enzymes & Kits & Reagents Market by Product, Application, End user and Region - Global Forecast to 2026" - https://www.reportlinker.com/p05144556/?utm_source=GNW
These processes require the use of various molecular biology enzymes and reagents and are thus expected to drive the molecular biology enzymes and kits & reagents market. However, factors such as limited reimbursements for genetic testing is likely to hinder the growth of this market.

The kits & reagents segment accounted for the highest growth rate in the molecular biology enzymes and kits & reagents market, by product, during the forecast period
The molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. The kits & reagents segment accounted for the largest share of 85.9% of the global molecular biology enzymes and kits & reagents market in 2020. The large share of this segment can primarily be attributed to the repeat purchase of these single-use products. This segment is also expected to grow at the highest rate owing to its wide applications by pharmaceutical & biotechnology companies.

Polymerase chain reaction (PCR) segment accounted for the largest share
Based on applications, the global molecular biology enzymes and kits & reagents market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection).
The polymerase chain reaction (PCR) segment accounted for the largest share of the molecular biology enzymes and kits & reagents market in 2020, mainly due to the low cost of PCR equipment, the extensive use of PCR equipment by a majority of end users, and the increasing use of PCR for molecular diagnostic assays in hospitals and clinics.

Asia Pacific: The fastest-growing region in the molecular biology enzymes and kits & reagents market
The molecular biology enzymes and kits & reagents market is segmented into North America, Europe, Asia Pacific, RoW.The molecular biology enzymes and kits & reagents market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period.

Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and the growing outsourcing of clinical research activities to Asian countries.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level - 25%, D-level - 20%, and Others - 55%
• By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Lists of Companies Profiled in the Report:
• Thermo Fisher (US)
• Merck (Germany)
• Illumina (US)
• QIAGEN (Netherlands)
• New England Biolabs (US)
• Promega (US)
• Agilent (US)
• Roche (Switzerland)
• Takara Bio (Japan)
• Bio Basic (Canada)
• Jena Bioscience (Germany)
• Molecular Biology Resources (US)
• Bio-Rad Laboratories Inc. (US)
• Zymo Research Corporation (US)
• Integrated DNA Technologies Inc. (US)
• LGC Biosearch Technologies (UK)
• NZYTech (Portugal) Lucigen Corporation (US)
• MoBiTec GmbH (Germany)
• Genekam Biotechnology (Germany)
• Aldevron (US) Randox (Northern Ireland)
• ADS Biotec Inc. (US)
• Hangzhou Matridx Biotechnology Co. Ltd. (China)
• Goldsite Diagnostics Inc. (China)

Research Coverage:
This report provides a detailed picture of the molecular biology enzymes and kits & reagents market.It aims at estimating the size and future growth potential of the market across different segments such as the service end user and region.

The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall molecular biology enzymes and kits & reagents market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.

This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
Read the full report: https://www.reportlinker.com/p05144556/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting